U.S. losartan market totals approximately $241M annually with around 72M prescriptions, creating a significant opportunity for ARBLI™ as the first FDA-approved ready-to-use oral suspension COMMACK, NY ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results